U.S. Electric Utilities Stock News

Trending interest in Sagimet Biosciences (SGMT) centers on its recent acne pipeline update, with plans to file an IND for denifanstat and to move both denifanstat and TVB-3567 into later stage clinical trials. See our latest analysis for Sagimet Biosciences. Those acne trial plans and the recent follow on equity raise come after a sharp run in the shares, with a 30 day share price return of 53.68% and a 1 year total shareholder return of 104.33% from a latest share price of US$8.03. This...

Northeast Community Bancorp (NECB) has just posted another quarter of solid profitability, with Q4 2025 revenue at US$26.8 million and basic EPS at US$0.81, while trailing 12 month figures show revenue of US$104.9 million, net income of US$44.4 million and basic EPS of US$3.35. Over the last few quarters, revenue has ranged from US$24.4 million in Q4 2024 to US$27.5 million in Q3 2024 as quarterly EPS moved between US$0.78 and US$0.97. This sets up a story where investors are watching how a...

Kymera Therapeutics Q1 2026 earnings snapshot Kymera Therapeutics (KYMR) has kicked off Q1 2026 with the market watching closely after recent quarters that paired modest revenue with sizeable losses, including Q4 2025 revenue of US$2.9 million and a basic EPS loss of US$0.97 on net income excluding extra items of a US$87 million loss. Over the past year, the company has seen quarterly revenue range from US$2.8 million to US$22.1 million, while basic EPS losses moved between US$0.82 and...

Caterpillar Q1 2026 earnings set the stage for mixed margin signals Caterpillar (CAT) has just opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$67.6b in revenue and US$8.9b in net income, with full year 2025 Q4 revenue at US$19.1b and basic EPS of US$5.15 anchoring the latest reported quarter. Over recent quarters the company has seen revenue move from US$16.2b in Q4 2024 to US$19.1b in Q4 2025, while quarterly basic EPS has ranged from US$4.22 in Q1 2025 to...

If you are trying to work out whether Qfin Holdings at around US$13.08 is a bargain or a value trap, the recent share performance gives you a useful starting point. The stock has seen mixed returns, with a 2.6% gain over the last 7 days and 1.3% over the last 30 days, set against a 31.3% year to date decline and a 64.8% decline over the past year. Those moves sit within a longer track record where 3 year returns are 11.5% lower and 5 year returns are 28.4% lower. This can influence how the...

This article examines whether Henry Schein, trading at around US$74, is priced fairly or presents a potential mispricing opportunity by breaking down what the current share price might be implying. The stock is up 15.7% over the past year, while the year-to-date return is a 2.9% decline, with a 4.6% drop over the last week and a 1.2% gain over the past month. Recent coverage has focused on Henry Schein as a healthcare supplier navigating changes in demand across dental and medical markets,...

Cimpress (CMPR) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue running between about US$789 million and US$1.0 billion, while Basic EPS across those periods ranged from a loss of US$1.02 to a profit of US$2.45 per share as net income swung between losses and profits. Over the past few quarters, the company has seen revenue move from US$789.5 million in Q3 2025 to US$1.04 billion in Q2 2026, with EPS shifting from a loss of US$0.33 per share to a gain of US$2.01...

KLA (KLAC) has put another solid quarter on the table, with Q3 2026 revenue of US$3.4b, basic EPS of US$9.17 and trailing twelve month EPS of US$35.52 setting the tone for its latest results. The company has seen revenue move from US$3.1b in Q2 2025 to US$3.4b in Q3 2026, while quarterly EPS has ranged from US$6.18 to US$9.17 over that period. This gives a clear view of how the top line and per share earnings have tracked into this release as margins support the story. See our full analysis...

USA TODAY (TDAY) opened Q1 2026 reporting Q4 2025 revenue of US$585.0 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$30.1 million. The trailing twelve months to Q4 2025 showed total revenue of about US$2.3 billion and basic EPS of US$0.01. Over recent quarters the company has reported revenue between US$560.8 million and US$621.3 million, with EPS ranging from a profit of US$0.54 in Q2 2025 to several loss-making quarters. Investors are likely...

TTM Technologies (TTMI) opened 2026 with Q1 revenue of US$846.0 million and basic EPS of US$0.48, alongside trailing 12 month EPS of US$1.89 on US$3.1 billion of revenue. This gives investors a clear view of both the latest quarter and the broader run rate. Over the past year, the company’s quarterly revenue moved from US$648.7 million in Q1 2025 to US$846.0 million in Q1 2026. Basic EPS over the same quarters shifted from US$0.32 to US$0.48, while trailing 12 month net income climbed from...

Iron Mountain (IRM) has kicked off its latest reporting cycle with Q1 2026 framed against a year where trailing twelve month revenue reached about US$6.9b and basic EPS came in at US$0.49, giving investors a clear view of how headline results are feeding through to the bottom line. Over recent quarters the company has seen revenue move from US$1,581.3m in Q4 2024 to US$1,843.2m in Q4 2025, while quarterly basic EPS has ranged from US$0.35 to US$0.30 across the same period. This sets the...

Donegal Group (DGICA) has just opened its Q1 2026 reporting season with trailing 12 month revenue of US$978.0 million and basic EPS of US$2.18, alongside net income of US$79.3 million anchored in its recent quarterly run rate. Over recent quarters the company has seen revenue move from US$249.9 million in Q4 2024 to US$245.2 million in Q1 2025 and then US$240.1 million by Q4 2025, with quarterly EPS ranging between roughly US$0.47 and US$0.71. This sets up an earnings print where margins and...

Cardinal Health Q3 2026 Earnings Snapshot Cardinal Health (CAH) has put up another big quarter, with Q2 2026 revenue at US$65.6b, basic EPS of US$1.98 and net income of US$467m setting the tone for its latest earnings update. Over the past six reported quarters, revenue has moved from US$52.3b in Q1 2025 to US$65.6b in Q2 2026, while basic EPS has ranged from US$1.00 in Q4 2025 to US$2.11 in Q3 2025. This gives you a clear line of sight on how the top line and EPS have tracked together. With...

Equinix (EQIX) opened Q1 2026 with total revenue of US$2.4 billion and basic EPS of US$4.22, while trailing twelve month revenue stood at US$9.5 billion and EPS at US$14.50 to frame the latest quarterly print against the broader run rate. Over the past year, revenue has moved from US$8.7 billion in Q4 2024 to US$9.5 billion in Q1 2026, with basic EPS over that same period running from US$8.54 to US$14.50, setting expectations for how you read this quarter’s margin profile and earnings power...

Booking Holdings (BKNG) just turned in its Q1 2026 scorecard, reporting revenue of US$5.5b and basic EPS of US$1.37. This is set against trailing twelve month revenue of US$27.7b and EPS of US$7.66, which have been growing at 7.9% and 13.1% per year respectively. Over the past year, revenue has moved from US$24.1b to US$27.7b while basic EPS has shifted from US$6.54 to US$7.66, giving you a clear view of how the top line and earnings are tracking together. Overall, margins around the 22% mark...

Indivior Pharmaceuticals (INDV) has come off a strong finish to 2025, with Q4 total revenue of US$358 million, basic EPS of US$0.82, and trailing twelve month figures showing total revenue of US$1.2 billion and basic EPS of US$1.68. Over recent quarters the company has seen revenue move from US$299 million in Q4 2024 to US$358 million in Q4 2025, while quarterly basic EPS shifted from US$0.17 in Q4 2024 to US$0.82 in Q4 2025. This sets up the latest results release as a key check on how...

Group 1 Automotive (GPI) has just posted fresh Q1 2026 numbers, coming off a recent quarter where Q4 2025 revenue sat at US$5.6b and basic EPS was US$3.48 as part of a trailing twelve month profile of US$22.6b in revenue and EPS of US$25.17. Over recent quarters the company has seen revenue move from US$5.5b in Q1 2025 to US$5.8b in Q3 2025 and US$5.6b in Q4 2025, while quarterly basic EPS ranged from US$1.03 to US$10.78 across 2025. This has set up a results season where investors are...

Wondering whether Flagstar Bank National Association at US$13.81 is offering genuine value or just looks cheap on the surface? This article walks through what the current share price may be implying. The stock has returned 7.3% over the last 30 days and 10.0% year to date, while the 1 year return sits at 18.3%. This is despite longer term 3 year and 5 year returns of 49.7% and 53.4% declines. Recent coverage around the stock has focused on its position within the U.S. banking sector and how...

If you are wondering whether Life Time Group Holdings is priced attractively right now, it helps to start by looking at how its current share price lines up with several valuation checks. The stock closed at US$26.23, with returns of a 5.7% decline over the last 7 days, 0.6% over 30 days, a 1.7% decline year to date, and a 14.4% decline over the past year, while the 3 year return stands at 30.5%. These figures can shape how investors think about both potential and risk. Recent coverage...

Washington, D.C. sues Mid-America Apartment Communities (NYSE:MAA) and subsidiaries over allegedly illegal and hidden tenant fees. The complaint claims tenants were misled by advertised rents that did not reflect required add on charges. The case focuses on properties in the District and raises questions about fee practices in large multifamily portfolios. Mid-America Apartment Communities, a large multifamily REIT, focuses on apartment communities across U.S. growth markets. The...

Hilton Worldwide Holdings (NYSE:HLT) is highlighting strong net unit growth that exceeded its own guidance, alongside record hotel openings, beyond the usual Q1 earnings focus. The company is rolling out new AI tools, including a Hilton AI Planner, aimed at improving planning, efficiency, and guest engagement across its global portfolio. These moves come as Hilton continues to expand in a period of geopolitical challenges, signaling an operational shift that goes beyond headline financial...

Considering whether Zai Lab at US$20.75 is starting to look like value after a rough few years, or whether the risks still outweigh the potential upside. The share price has been volatile recently, with a 9.3% decline over the last 7 days, a 16.2% gain over the past month, and a 19.7% return year to date. The 1 year return sits at a 34.5% decline and the 5 year return at an 86.3% decline. Recent price moves sit against a backdrop of ongoing interest in biotech names, regulatory developments,...

Cleveland-Cliffs (NYSE:CLF) has signaled interest in entering rare earths mining in Michigan and Minnesota. The move is linked to efforts around U.S. critical material independence and could expand the company beyond its core steel operations. The company is exploring how potential projects could fit alongside its existing footprint in the Upper Midwest. Cleveland-Cliffs, trading at $10.25, is primarily known as an integrated steel and iron ore producer, so rare earths would be a new line...

With Synchrony Financial at US$75.12, you might be wondering whether the recent share price leaves the stock looking cheap, expensive or somewhere in between. Over the short term the stock has been mixed, with a 4.5% decline over the last 7 days but a 13.8% gain over 30 days, while longer term returns of 47.2% over 1 year, 187.8% over 3 years and 86.7% over 5 years show how much the share price has moved over time. Recent headlines around Synchrony Financial have focused on its position in...